An evolving curse on paracetamol use in children
- 1*
- 1Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Kadhirkamam, Puducherry, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Sivagnanam G
Department of Pharmacology, Indira Gandhi Medical College and Research Institute, Kadhirkamam, Puducherry, India.
Email: drsivagnanam@gmail.com
Copyright: © 2014 The Author(s). This is an open access article.
Published: Jan 1, 2014
- DOI
- Not available yet
Abstract
The association between acetaminophen and asthma - should its pediatric use be banned? A huge epidemiological effort made all over the world to cast some light on the origin of asthma and its recent increase in prevalence has been made. The focus on genetic factors has failed to show a strong signal. Environmental factors have provided some variable signals (from protecting to inducing asthma) on the role of infections, allergens and bacterial substances. The only large and consistent epidemiological signal (apart from tobacco exposure), is previous acetaminophen (paracetamol) exposure, which consistently increases the prevalence and clinical manifestations of every wheezing disorder. Is acetaminophen a real asthma promoter or an innocent bystander?[1] The main mechanism suggested is that acetaminophen may impair respiratory antioxidant defenses by decreasing the amount of reduced glutathione present in the airways, which would increase the airway oxygen radicals with attendant detrimental effects: Tissue injury, smooth muscle contraction, bronchial hyper-responsiveness, increased vascular permeability, release of proinflammatory mediators and impaired β-receptor function.[2] Another possible mechanism offered could be related to its antipyretic effect: By reducing fever, acetaminophen may reduce the cytokine storm that takes place as a part of the febrile response, mainly the production of IFN-γ and IL2.[3] For the present whatever may be the evidence (for or against), smoke has started to arise as for as the use of paracetamol and association of wheeze, in pediatric cases. So it is concluded, too liberal use of acetaminophen in children should no longer be recommended since there is a good deal of epidemiological evidence suggesting that acetaminophen exposure increases wheezing disorders prevalence, and while awaiting the results of appropriate randomized clinical trials it seems reasonable to limit acetaminophen exposure to clinical settings where no alternatives (ibuprofen) exist. In wheezing children, using ibuprofen has proved to decrease wheezing morbidity.[1]
Subject
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026